156 related articles for article (PubMed ID: 21365508)
41. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
[TBL] [Abstract][Full Text] [Related]
42. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
43. Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Scally CP; Fournier KF; Mansfield PF
JAMA Surg; 2021 Mar; 156(3):e206364. PubMed ID: 33502464
[No Abstract] [Full Text] [Related]
44. Peritoneal pseudomyxoma arising from the urachus.
Martínez A; Ferron G; Mery E; Gladieff L; Delord JP; Querleu D
Surg Oncol; 2012 Mar; 21(1):1-5. PubMed ID: 20189378
[TBL] [Abstract][Full Text] [Related]
45. Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery.
Dohan A; Barral M; Eveno C; Lo Dico R; Kaci R; Pasteur-Rousseau A; Soyer P; Pocard M; Bonnin P
Eur J Surg Oncol; 2017 Oct; 43(10):1932-1938. PubMed ID: 28587731
[TBL] [Abstract][Full Text] [Related]
46. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
[TBL] [Abstract][Full Text] [Related]
47. Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: incidence, risk factors, management, and clinical sequelae.
Saxena A; Chua TC; Yan TD; Morris DL
Ann Surg Oncol; 2010 May; 17(5):1302-10. PubMed ID: 20087784
[TBL] [Abstract][Full Text] [Related]
48. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
[TBL] [Abstract][Full Text] [Related]
49. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
[TBL] [Abstract][Full Text] [Related]
50. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
Sugarbaker PH
Br J Surg; 2002 Feb; 89(2):208-12. PubMed ID: 11856136
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of fibrinogen concentrate in major abdominal surgery - A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei.
Roy A; Stanford S; Nunn S; Alves S; Sargant N; Rangarajan S; Smith EA; Bell J; Dayal S; Cecil T; Tzivanakis A; Kruzhkova I; Solomon C; Knaub S; Moran B; Mohamed F
J Thromb Haemost; 2020 Feb; 18(2):352-363. PubMed ID: 31654548
[TBL] [Abstract][Full Text] [Related]
52. Regarding "two steps procedure for pseudomyxoma".
Pocard M; Eveno C; Valleur P
Ann Surg Oncol; 2011 Jan; 18(1):282-3; author reply 284-5. PubMed ID: 20645012
[No Abstract] [Full Text] [Related]
53. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
López-López V; Cascales-Campos PA; Gil E; Arevalo J; Gonzalez A; Gil J; Muñoz-Casares FC; Melero JT; Barrios P; Morales R; Ramos I; Ortega G; Camps B; González-Bayón L; Bretcha-Boix P; Farré-Alegre J; González-Moreno S; Parrilla P
Clin Transl Oncol; 2017 Nov; 19(11):1388-1392. PubMed ID: 28812240
[TBL] [Abstract][Full Text] [Related]
54. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
[TBL] [Abstract][Full Text] [Related]
55. Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
Invest New Drugs; 2012 Oct; 30(5):2080-6. PubMed ID: 22359216
[TBL] [Abstract][Full Text] [Related]
56. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Hosch WP; Rudi J; Stremmel W
Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
[TBL] [Abstract][Full Text] [Related]
57. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
Güner Z; Schmidt U; Dahlke MH; Schlitt HJ; Klempnauer J; Piso P
Int J Colorectal Dis; 2005 Mar; 20(2):155-60. PubMed ID: 15503065
[TBL] [Abstract][Full Text] [Related]
58. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei (Br J Surg 2001; 88: 458-63).
Jähne J
Br J Surg; 2001 Aug; 88(8):1130. PubMed ID: 11488802
[No Abstract] [Full Text] [Related]
59. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy].
Scuderi S; Costamagna D; Vaira M; Barone R; De Simone M
Tumori; 2003; 89(4 Suppl):43-5. PubMed ID: 12903542
[TBL] [Abstract][Full Text] [Related]
60. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
Hsu KH; Chou CY; Chang YC
Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
